Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 76
Filter
1.
J Endocrinol Invest ; 47(6): 1405-1418, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38218741

ABSTRACT

OBJECTIVES: To examine the cross-sectional association between baseline depressive symptoms and the presence of type 2 diabetes (T2D), and its association with glycated hemoglobin (HbA1c) and other metabolic variables, and the prospective association of depressive symptoms and HbA1c after 1 year of follow-up. METHODS: n = 6224 Mediterranean older adults with overweight/obesity and metabolic syndrome (48% females, mean age 64.9 ± 4.9 years) were evaluated in the framework of the PREDIMED-Plus study cohort. Depressive symptoms were assessed using the Beck Depression Inventory-II and HbA1c was used to measure metabolic control. RESULTS: The presence of T2D increased the likelihood of higher levels of depressive symptoms (χ2 = 15.84, p = 0.001). Polynomial contrast revealed a positive linear relationship (χ2 = 13.49, p = 0.001), the higher the depressive symptoms levels, the higher the prevalence of T2D. Longitudinal analyses showed that the higher baseline depressive symptoms levels, the higher the likelihood of being within the HbA1c ≥ 7% at 1-year level (Wald-χ2 = 24.06, df = 3, p < .001, for the full adjusted model). Additionally, depressive levels at baseline and duration of T2D predicted higher HbA1c and body mass index, and lower physical activity and adherence to Mediterranean Diet at 1 year of follow-up. CONCLUSIONS: This study supports an association between T2D and the severity of depressive symptoms, suggesting a worse metabolic control from mild severity levels in the short-medium term, influenced by lifestyle habits related to diabetes care. Screening for depressive symptoms and a multidisciplinary integrative therapeutic approach should be ensured in patients with T2D.


Subject(s)
Depression , Diabetes Mellitus, Type 2 , Humans , Diabetes Mellitus, Type 2/psychology , Diabetes Mellitus, Type 2/epidemiology , Diabetes Mellitus, Type 2/complications , Female , Male , Middle Aged , Follow-Up Studies , Depression/epidemiology , Depression/etiology , Aged , Cross-Sectional Studies , Glycated Hemoglobin/analysis , Prospective Studies , Diet, Mediterranean , Prevalence , Body Mass Index , Obesity/psychology , Obesity/epidemiology , Obesity/complications , Metabolic Syndrome/epidemiology , Metabolic Syndrome/psychology
2.
J Nutr Health Aging ; 27(12): 1162-1167, 2023.
Article in English | MEDLINE | ID: mdl-38151866

ABSTRACT

OBJECTIVES: We tested the effects of a weight-loss intervention encouraging energy-reduced MedDiet and physical activity (PA) in comparison to ad libitum MedDiet on COVID-19 incidence in older adults. DESIGN: Secondary analysis of PREDIMED-Plus, a prospective, ongoing, multicentre randomized controlled trial. SETTING: Community-dwelling, free-living participants in PREDIMED-Plus trial. PARTICIPANTS: 6,874 Spanish older adults (55-75 years, 49% women) with overweight/obesity and metabolic syndrome. INTERVENTION: Participants were randomised to Intervention (IG) or Control (CG) Group. IG received intensive behavioural intervention for weight loss with an energy-reduced MedDiet intervention and PA promotion. CG was encouraged to consume ad libitum MedDiet without PA recommendations. MEASUREMENTS: COVID-19 was ascertained by an independent Event Committee until December 31, 2021. COX regression models compared the effect of PREDIMED-Plus interventions on COVID-19 risk. RESULTS: Overall, 653 COVID-19 incident cases were documented (IG:317; CG:336) over a median (IQR) follow-up of 5.8 (1.3) years (inclusive of 4.0 (1.2) years before community transmission of COVID-19) in both groups. A significantly lowered risk of COVID-19 incidence was not evident in IG, compared to CG (fully-adjusted HR (95% CI): 0.96 (0.81,1.12)). CONCLUSIONS: There was no evidence to show that an intensive weight-loss intervention encouraging energy-reduced MedDiet and PA significantly lowered COVID-19 risk in older adults with overweight/obesity and metabolic syndrome in comparison to ad libitum MedDiet. Recommendations to improve adherence to MedDiet provided with or without lifestyle modification suggestions for weight loss may have similar effects in protecting against COVID-19 risk in older adults with high cardiovascular risks.


Subject(s)
COVID-19 , Cardiovascular Diseases , Diet, Mediterranean , Metabolic Syndrome , Humans , Female , Aged , Male , Metabolic Syndrome/epidemiology , Metabolic Syndrome/prevention & control , Metabolic Syndrome/complications , Overweight/complications , Prospective Studies , Cardiovascular Diseases/etiology , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19/complications , Obesity/complications , Obesity/epidemiology , Obesity/therapy , Life Style , Weight Loss
3.
Rev. esp. cardiol. (Ed. impr.) ; 75(8): 649-658, ago. 2022. tab, graf
Article in Spanish | IBECS | ID: ibc-207891

ABSTRACT

Introducción y objetivos La desregulación del metabolismo de los ácidos grasos en la mitocondria es un mecanismo involucrado en el desarrollo de insuficiencia cardiaca (IC) y fibrilación auricular (FA). Se evaluó la asociación entre la concentración plasmática de acilcarnitinas y la incidencia de IC o FA y si la dieta mediterránea (DietMed) puede atenuar la asociación entre las acilcarnitinas y el riesgo de IC o FA. Métodos Dos estudios de casos y controles anidados en el ensayo Prevención con dieta mediterránea (PREDIMED). Se incluyó a participantes con elevado riesgo cardiovascular en España: 326 casos incidentes de IC y 509 de FA se emparejaron individualmente con 1 a 3 controles. Las acilcarnitinas en plasma se midieron con espectrometría de masas en tándem con cromatografía líquida de alta resolución. Se ajustaron modelos de regresión logística condicional para estimar las OR multivariables y los IC95%. Se evaluaron interacciones multiplicativas y aditivas por el grupo de intervención, obesidad (índice de masa corporal ≥ 30) y diabetes mellitus tipo 2. Resultados Las altas concentraciones de acilcarnitinas de cadena mediana y larga se asociaron con un mayor riesgo de IC (respectivamente, ORporDE ajustada=1,28; IC95%, 1,09-1,51, y ORporDE ajustada=1,21; IC95%, 1,04-1,42). Se observó una asociación significativa entre las acilcarnitinas de cadena larga y el riesgo de FA: 1,20 (1,06-1,36). Se encontró una interacción aditiva entre las acilcarnitinas de cadena larga y la FA con la DietMed suplementada con aceite de oliva virgen extra (p de interacción=0,036) y con la obesidad (p=0,022) de forma inversa y directa respectivamente. Conclusiones En las personas con alto riesgo cardiovascular, las altas concentraciones de acilcarnitinas de cadena larga se asocian con mayor riesgo de IC y FA incidentes. Una intervención con DietMed+aceite de oliva virgen extra puede reducir el riesgo asociado con las acilcarnitinas de cadena larga (AU)


Introduction and objectives Fatty acid metabolic dysregulation in mitochondria is a common mechanism involved in the development of heart failure (HF) and atrial fibrillation (AF). We evaluated the association between plasma acylcarnitine levels and the incidence of HF or AF, and whether the mediterranean diet (MedDiet) may attenuate the association between acylcarnitines and HF or AF risk. Methods Two case-control studies nested within the Prevención con dieta mediterránea (PREDIMED) trial. High cardiovascular risk participants were recruited in Spain: 326 incident HF and 509 AF cases individually matched to 1 to 3 controls. Plasma acylcarnitines were measured with high-throughput liquid chromatography-tandem mass spectrometry. Conditional logistic regression models were fitted to estimate multivariable OR and 95%CI. Additive and multiplicative interactions were assessed by intervention group, obesity (body mass index ≥ 30 kg/m2), and type 2 diabetes. Results Elevated levels of medium- and long-chain acylcarnitines were associated with increased HF risk (adjusted ORperDE, 1.28; 95%CI, 1.09-1.51 and adjusted ORperDE, 1.21; 95%CI, 1.04-1.42, respectively). A significant association was observed for AF risk with long-chain acylcarnitines: 1.20 (1.06-1.36). Additive interaction of the association between long-chain acylcarnitines and AF by the MediDiet supplemented with extra virgin olive oil (P for additive interaction=.036) and by obesity (P=.022) was observed in an inverse and direct manner, respectively. Conclusions Among individuals at high cardiovascular risk, elevated long-chain acylcarnitines were associated with a higher risk of incident HF and AF. An intervention with MedDiet+extra-virgin olive oil may reduce AF risk associated with long-chain acylcarnitines (AU)


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Heart Failure/prevention & control , Atrial Fibrillation/prevention & control , Carnitine/analogs & derivatives , Diet, Mediterranean , Heart Failure/etiology , Obesity/complications , Risk Factors , Biomarkers/blood , Carnitine/blood
4.
Eur J Prev Cardiol ; 28(6): 648-657, 2021 05 22.
Article in English | MEDLINE | ID: mdl-34021573

ABSTRACT

AIMS: The association between caffeinated coffee consumption and atrial fibrillation remains unclear. Recent studies suggest an inverse association only between a moderate caffeinated coffee consumption and atrial fibrillation, but others have reported no association. The aim of our study was to prospectively assess the association between caffeinated coffee consumption and atrial fibrillation in two Spanish cohorts, one of adults from a general population and another of elderly participants at high cardiovascular risk. METHODS AND RESULTS: We included 18,983 and 6479 participants from the 'Seguimiento Universidad de Navarra' (SUN) and 'Prevención con Dieta Mediterránea' (PREDIMED) cohorts, respectively. Participants were classified according to their caffeinated coffee consumption in three groups: ≤3 cups/month, 1-7 cups/week, and >1 cup/day. We identified 97 atrial fibrillation cases after a median follow-up of 10.3 years (interquartile range 6.5-13.5), in the SUN cohort and 250 cases after 4.4 years median follow-up (interquartile range 2.8-5.8) in the PREDIMED study. No significant associations were observed in the SUN cohort although a J-shaped association was suggested. A significant inverse association between the intermediate category of caffeinated coffee consumption (1-7 cups/week) and atrial fibrillation was observed in PREDIMED participants with a multivariable-adjusted hazard ratio = 0.53 (95% confidence interval 0.36-0.79) when compared with participants who did not consume caffeinated coffee or did it only occasionally. No association was found for higher levels of caffeinated coffee consumption (>1 cup per day), hazard ratio = 0.79 (95% confidence interval 0.49-1.28). In the meta-analysis of both PREDIMED and SUN studies, the hazard ratio for intermediate consumption of caffeinated coffee was 0.60 (95% confidence interval 0.44-0.82) without evidence of heterogeneity. Similar findings were found for the association between caffeine intake and atrial fibrillation risk. CONCLUSION: Intermediate levels of caffeinated coffee consumption (1-7 cups/week) were associated with a reduction in atrial fibrillation risk in two prospective Mediterranean cohorts.


Subject(s)
Atrial Fibrillation , Coffee , Adult , Aged , Atrial Fibrillation/diagnosis , Atrial Fibrillation/epidemiology , Coffee/adverse effects , Cohort Studies , Humans , Proportional Hazards Models , Prospective Studies , Risk Factors
5.
Semergen ; 46(8): 524-537, 2020.
Article in English | MEDLINE | ID: mdl-32540410

ABSTRACT

INTRODUCTION AND OBJECTIVES: Metabolic syndrome (MetS) is a combination of various cardiovascular risk factors with a major impact on morbidity and premature mortality. However, the impact of MetS on self-reported health-related quality of life (HRQoL) is unknown. This study evaluated the HRQoL in a Spanish adult population aged 55 years and older with MetS. METHOD: A cross-sectional analysis was performed with baseline data from the PREDIMED-Plus multicentre randomized trial. The participants were 6430 men and women aged 55-75 years with overweight/obesity (body mass index ≥27 and ≤40kg/m2) and MetS. The SF-36 questionnaire was used as a tool to measure HRQoL. Scores were calculated on each scale of the SF-36 by gender and age. RESULTS: Participants showed higher scores in the social function (mean 85.9, 95% CI; 85.4-86.4) and emotional role scales (mean 86.8, 95% CI; 86.0-87.5). By contrast, the worst scores were obtained in the aggregated physical dimensions. In addition, men obtained higher scores than women on all scales. Among men, the worst score was obtained in general health (mean 65.6, 95% CI; 65.0-66.2), and among women, in body pain (mean 54.3, 95%CI; 53.4-55.2). A significant decrease was found in the aggregated physical dimensions score among participants 70-75 years old, but an increased one in the aggregated mental dimensions, compared to younger participants. CONCLUSIONS: Our results reflect that the MetS may negatively affect HRQoL in the aggregated physical dimensions, body pain in women, and general health in men. However, this adverse association was absent for the psychological dimensions of HRQoL, which were less affected.


Subject(s)
Metabolic Syndrome , Quality of Life , Aged , Body Mass Index , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Surveys and Questionnaires
6.
Clin Nutr ; 39(3): 966-975, 2020 03.
Article in English | MEDLINE | ID: mdl-31053509

ABSTRACT

BACKGROUND & AIMS: Little is known about the impact of specific dietary patterns on the development of obesity phenotypes. We aimed to determine the association of longitudinal changes in adherence to the traditional Mediterranean diet (MedDiet) with the transition between different obesity phenotypes. METHODS: Data of 5801 older men and women at high cardiovascular risk from PREDIMED trial were used. Adherence to MedDiet was measured with the validated 14p-Mediterranean Diet Adherence Screener (MEDAS). Using the simultaneous combination of metabolic health- and body size-related parameters participants were categorized into one of four phenotypes: metabolically healthy and abnormal obese (MHO and MAO), metabolically healthy and abnormal non-obese (MHNO and MANO). Cox regression models with yearly repeated measures during 5-year of follow-up were built with use of Markov chain assumption. RESULTS: Each 2-point increase in MEDAS was associated with the following transitions: in MAO participants, with a 16% (95% CI 3-31%) greater likelihood of becoming MHO; in MHO participants with a 14% (3-23%) lower risk of becoming MAO; in MHNO participants with a 18% (5-30%) lower risk of becoming MHO. In MANO women, but not in men, MEDAS was associated with 20% (5-38%) greater likely of becoming MHNO (p for interaction by gender 0.014). No other significant associations were observed. CONCLUSIONS: Better adherence to the traditional MedDiet is associated with transitions to healthier phenotypes, promoting metabolic health improvement in MAO, MANO (only in women), and MHO, as well as protecting against obesity incidence in MHNO subjects.


Subject(s)
Body Mass Index , Diet, Mediterranean/statistics & numerical data , Geriatric Assessment/methods , Obesity/diet therapy , Patient Compliance/statistics & numerical data , Aged , Female , Humans , Longitudinal Studies , Male , Phenotype
7.
Nutr Metab Cardiovasc Dis ; 29(7): 676-683, 2019 07.
Article in English | MEDLINE | ID: mdl-31078364

ABSTRACT

BACKGROUND AND AIMS: There is ongoing controversy about the effect of a low to moderate alcohol consumption on atrial fibrillation (AF). Our aim is to assess the association between adherence to a Mediterranean alcohol drinking pattern and AF incidence. METHODS AND RESULTS: A total 6527 out of the 7447 participants in the PREDIMED trial met our inclusion criteria. A validated frequency food questionnaire was used to measure alcohol consumption. Participants were classified as non-drinkers, Mediterranean alcohol drinking pattern (MADP) (10-30 g/d in men and 5-15 g/day in women, preferably red wine consumption with low spirits consumption), low-moderate drinking (<30 g/day men y and < 15 g/day women), and heavy drinking. We performed multivariable Cox regression models to estimate hazard ratios (HR) with 95% confidence intervals (95% CI) of incident AF according to alcohol drinking patterns. After a mean follow up of 4.4 years, 241 new incident AF cases were confirmed. Alcohol consumption was not associated to AF incidence among low-moderate drinkers (HR: 0.96; 95%CI: 0.67-1.37), adherents to MADP (HR: 1.15 95%CI: 0.75-1.75), or heavy drinkers (HR: 0.92; 95%CI: 0.53-1.58), compared with non-drinkers. CONCLUSIONS: In a high cardiovascular risk adult population, a Mediterranean alcohol consumption pattern (low to moderate red wine consumption) was not associated with an increased incidence of AF. CLINICAL TRIALS: URL: http://www.controlled-trials.com. Unique identifier: ISRCTN35739639.


Subject(s)
Alcohol Drinking/trends , Atrial Fibrillation/epidemiology , Diet, Mediterranean , Feeding Behavior , Wine , Aged , Aged, 80 and over , Alcohol Drinking/adverse effects , Alcohol Drinking/epidemiology , Atrial Fibrillation/diagnosis , Female , Humans , Incidence , Male , Middle Aged , Prognosis , Prospective Studies , Risk Assessment , Risk Factors , Spain/epidemiology , Time Factors , Wine/adverse effects
8.
Neurochem Int ; 62(6): 873-80, 2013 May.
Article in English | MEDLINE | ID: mdl-23466408

ABSTRACT

Melatonin has been found in the digestive tract of many vertebrates. However, the enzymatic activity of the arylalkylamine-N-acetyltransferase (AANAT) and the hydroxindole-O-methyltransferase (HIOMT), the last two enzymes of melatonin biosynthesis, have been only measured in rat liver. Therefore, the first objective of the present study is to investigate the functionality of these enzymes in the liver and gut of goldfish, analyzing its possible daily changes and comparing its catalytic properties with those from the retina isoforms. The daily rhythms with nocturnal acrophases in retinal AANAT and HIOMT activities support their role in melatonin biosynthesis. In foregut AANAT activity also show a daily rhythm while in liver and hindgut significant but not rhythmic levels of AANAT activity are found. HIOMT activity is not detected in any of these peripheral tissues suggesting an alternative role for AANAT besides melatonin synthesis. The failure to detect functional HIOMT activity in both, liver and gut, led us to investigate other physiological substrates for the AANAT, as dopamine, searching alternative roles for this enzyme in the goldfish gut. Dopamine competes with tryptamine and inhibits retinal, intestinal and hepatic N-acetyltryptamine production, suggesting that the active isoform in gut is AANAT1. Besides, gut and liver produces N-acetyldopamine in presence of acetyl coenzyme-A and dopamine. This production is not abolished by the presence of folic acid (arylamine N-acetyltransferase inhibitor) in any studied tissue, but a total inhibition occurs in the presence of CoA-S-N-acetyltryptamine (AANAT inhibitor) in liver. Therefore, AANAT1 seems to be an important enzyme in the regulation of dopamine and N-acetyldopamine content in liver. Finally, for the first time in fish we found that dopamine, but not N-acetyldopamine, regulates the gut motility, underlying the broad physiological role of AANAT in the gut.


Subject(s)
Arylalkylamine N-Acetyltransferase/metabolism , Arylalkylamine N-Acetyltransferase/physiology , Dopamine/metabolism , Dopamine/physiology , Gastrointestinal Motility/physiology , Gastrointestinal Tract/metabolism , Goldfish/physiology , Acetylation , Animals , Arylalkylamine N-Acetyltransferase/antagonists & inhibitors , Circadian Rhythm/physiology , Enzyme Inhibitors/pharmacology , Gastrointestinal Tract/drug effects , In Vitro Techniques , Liver/enzymology , Melatonin/metabolism , Retina/metabolism , Serotonin/analogs & derivatives , Serotonin/metabolism , Tryptamines/metabolism
9.
Gen Comp Endocrinol ; 175(1): 180-7, 2012 Jan 01.
Article in English | MEDLINE | ID: mdl-22134177

ABSTRACT

The aim of the present study was to localize and characterize 2-iodo-melatonin ([(125)I]Mel) binding sites in peripheral tissues of the teleost Tinca tinca. A wide distribution of [(125)I]Mel binding sites in peripheral locations of the tench is found, with highest densities being measured in the heart, gills and kidney, and low density of [(125)I]Mel binding sites in gastrointestinal tract, spleen, liver and gonads. Saturation, kinetics, and pharmacological approaches revealed the presence of, at least, two different [(125)I]Mel binding sites in the tench peripheral tissues. The unique characterized subtype in the heart fulfils all the criteria for a canonical melatonin receptor belonging to MT(1) family (the binding is saturable, reversible, and inhibited by GTP analogs), and gives support for the presence of a functional melatonin receptor in the heart of the tench. In contrast, kinetic and pharmacological studies in the kidney revealed the preponderance of a melatonin binding site belonging to the MT(3)-like receptor subtype. Moreover, the decrease of specific binding in both, heart and kidney membranes, and the decrease of affinity in the kidney, produced by the addition of a non-hydrolysable GTP analog, and sodium cations suggest the presence of G(i/o)-proteins (that mediate inhibition of cAMP formation) coupled to such melatonin binding sites. Our results also point to different G(i/o)-proteins involved in the underlying mechanism of melatonin binding sites activation in the kidney. Additionally, the kinetics of [(125)I]Mel binding in kidney membrane preparations is a highly thermosensitive process, being necessary to perform the assays at 4 °C since the equilibrium was not reached at 25 °C assay temperature. The time needed to complete association of [(125)I]Mel at such low temperature is only 15s, whereas 100s is required to displace [(125)I]Mel specific binding by the unlabeled melatonin in kidney membranes. Present results support previous reports on melatonin effects in the regulation of different physiological functions in teleost (as cardiovascular physiology and osmoregulation) acting through peripheral specific receptors.


Subject(s)
Cyprinidae/metabolism , Gills/metabolism , Kidney/metabolism , Melatonin/metabolism , Myocardium/metabolism , Receptors, Melatonin/metabolism , Animals , Binding Sites , GTP-Binding Proteins/metabolism , Iodine Radioisotopes , Temperature
10.
Neurogastroenterol Motil ; 22(12): e364-73, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20939846

ABSTRACT

BACKGROUND: Serotonin (5-HT) plays a critical role in several gastrointestinal functions in vertebrates. In teleosts lacking enterochromaffin cells, intestinal 5-HT originates from serotonergic enteric neurons. In the present study, the foregut of a stomachless teleost, the goldfish (Carassius auratus), was used to evaluate the in vitro effect of 5-HT on fish intestinal motility. We also studied the role of melatonin (MEL), an indoleamine sharing the biosynthetic pathway with 5-HT, as regulator of serotonergic activity. METHODS: An organ bath system, with longitudinal strips from the goldfish intestinal bulb attached to an isometric transducer was used to record foregut smooth muscle contractions. KEY RESULTS: Concentration-dependent curves of the contractile response exerted by 5-HT and its agonists, 5-methoxytryptamine (5-MT) and 5-carboxamidotryptamine (5-CT), suggest a receptor-mediated action, supported by the blockade by a general 5-HT antagonist, methysergide. The 5-HT-induced contraction was abolished in the presence of atropine, revealing the involvement of cholinergic transmission in gut actions of 5-HT. Furthermore, MEL inhibited the contractile effect of 5-HT and its agonists by up to 50%, which was counteracted by MEL antagonists. CONCLUSIONS & INFERENCES: We can provisionally propose that at least two different 5-HT receptor subtypes are involved in fish intestinal motility, a 5-HT4-like (5-MT-preferring) and a 5-HT7-like (5-CT- and fluphenazine-sensitive) receptor. In summary, our results indicate that 5-HT regulates the contractile activity of goldfish foregut through specific receptors located in cholinergic neurons, and that MEL can modulate these serotonergic actions through high-affinity membrane receptors.


Subject(s)
Goldfish/anatomy & histology , Melatonin/metabolism , Muscle Contraction/drug effects , Muscle Contraction/physiology , Muscle, Smooth/drug effects , Muscle, Smooth/physiology , Serotonin/pharmacology , Animals , Atropine/pharmacology , Dose-Response Relationship, Drug , Gastrointestinal Motility/drug effects , Gastrointestinal Motility/physiology , Goldfish/metabolism , Muscarinic Antagonists/pharmacology , Serotonin Antagonists/metabolism , Serotonin Receptor Agonists/metabolism
11.
J Biol Rhythms ; 24(2): 104-13, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19346448

ABSTRACT

Clock genes are known to be the molecular core of biological clocks of vertebrates. They are expressed not only in those tissues considered central pacemakers, but also in peripheral tissues. In the present study, partial cDNAs for 6 of the principal clock genes (Period 1-3 and Cryptochrome 1-3) were cloned from a teleost fish, the goldfish (Carassius auratus ). These genes showed high homology (approximately 90%) with the respective cDNAs of zebrafish (Danio rerio), the only other teleost from which clock genes have been cloned. The daily expression pattern of each gene in retina, gut, and liver of goldfish was investigated using quantitative RT-PCR and cosinor analysis. All clock genes analyzed in the retina showed circadian rhythmicity; however, only Per 2-3 and Cry 2-3 were rhythmic in goldfish liver and gut. The amplitude and phase of the expression in liver and gut were different from those found in goldfish retina. Such differences suggest that other cues, such as feeding time, may contribute to the entrainment of oscillators in goldfish liver and gut. Our results support the use of goldfish as a teleost model to investigate the location and functioning of the circadian oscillators.


Subject(s)
Biological Clocks/genetics , Circadian Rhythm/genetics , Flavoproteins , Gene Expression Regulation , Goldfish , Intracellular Signaling Peptides and Proteins , Animals , Cloning, Molecular , Cryptochromes , Flavoproteins/genetics , Flavoproteins/metabolism , Gastrointestinal Tract/cytology , Gastrointestinal Tract/physiology , Goldfish/anatomy & histology , Goldfish/genetics , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/metabolism , Liver/cytology , Liver/physiology , Molecular Sequence Data , Period Circadian Proteins , Retina/cytology , Retina/physiology , Tissue Distribution , Zebrafish Proteins
12.
Nefrologia ; 28 Suppl 6: 105-12, 2008.
Article in Spanish | MEDLINE | ID: mdl-18957020

ABSTRACT

Patients on peritoneal dialysis account for approximately 10% of individuals on dialysis and are very variably distributed throughout Spain, with a national mean of 47 procedures per million inhabitants. The high incidence of cardiovascular disease in patients on peritoneal dialysis is determined by the almost universal presence of traditional cardiovascular risk factors (diabetes, hypertension) and other risk factors secondary to uremia and the inflammatory process associated to atherosclerotic disease. The concomitant presence in clinical practice of highly diverse heart diseases in these patients makes relevant a number of considerations from the cardiological viewpoint that may be of interest for specialists in nephrology. This review analyzes some aspects of four cardiological conditions that are very common in patients on peritoneal dialysis: heart failure, coronary heart disease, valve involvement, and atrial fibrillation.


Subject(s)
Atrial Fibrillation , Coronary Disease , Heart Failure , Heart Valve Diseases , Nephrology , Peritoneal Dialysis , Atrial Fibrillation/diagnosis , Atrial Fibrillation/etiology , Coronary Disease/diagnosis , Coronary Disease/etiology , Heart Failure/diagnosis , Heart Failure/etiology , Heart Valve Diseases/diagnosis , Heart Valve Diseases/etiology , Humans , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/therapy , Risk Factors
13.
Gen Comp Endocrinol ; 155(3): 847-56, 2008 Feb 01.
Article in English | MEDLINE | ID: mdl-18177872

ABSTRACT

The aim of the present study was to characterize the central melatonin receptors in brain areas and ocular tissues of the teleost Tinca tinca. We investigated the temperature-dependence of 2-iodo-melatonin ([(125)I]Mel) binding in the optic tectum-tegmentum area and the neural retina. The binding of [(125)I]Mel showed a widespread distribution in brain and ocular tissues, with the highest density in the optic tectum-thalamus and the lowest in hindbrain. The [(125)I]Mel affinity was similar in all the studied tissues, and it was on the order of the low pM range. Saturation, kinetic and pharmacological studies showed the presence of a unique MT(1)-like melatonin binding site. In addition, the non-hydrolysable GTP analog, the GTPgammaS, and sodium cations induced a specific binding decrease in the optic tectum and neural retina, suggesting that such melatonin binding sites in the tench are coupled to G protein. Thus, these melatonin binding sites in optic tectum and neural retina fulfil the requirements of a real hormone receptor, the specific binding is rapid, saturable, and reversible, and is inhibited by GTP analogs. Additionally, a clear effect of temperature on such central melatonin receptors was found. Temperature did not modify the B(max) and K(d), but the kinetics of [(125)I]Mel binding resulted in a highly thermosensitive process in both tissues. Both association and dissociation rates (K(+1) and K(-1)) significantly increased with assay temperature (15-30 degrees C), but the K(d) constant (estimated as K(-1)/K(+1)) remained unaltered. In conclusion, this high thermal dependence of the melatonin binding to its receptors in the tench central nervous system supports the conclusion that temperature plays a key role in melatonin signal transduction in fish.


Subject(s)
Brain/metabolism , Cyprinidae/metabolism , Eye/metabolism , Receptors, Melatonin/metabolism , Temperature , Animals , Binding Sites , Body Temperature/physiology , Female , Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology , Iodine Radioisotopes/pharmacokinetics , Male , Melatonin/metabolism , Melatonin/pharmacokinetics , Protein Binding/drug effects , Sodium/pharmacology
14.
Brain Res ; 1029(2): 241-50, 2004 Dec 17.
Article in English | MEDLINE | ID: mdl-15542079

ABSTRACT

Melatonin is synthesized, with a circadian rhythm, in the pineal organ of vertebrates, high levels being produced during the scotophase and low levels during the photophase. The retina also produces melatonin, although in the case of the European sea bass, its secretion pattern appears to be inverted. In the study described here, radioreceptor assay techniques were used to characterize the melatonin binding sites, their regional distribution and their daily variations. Brain and retina membrane preparations were used in all the binding assays and 2-[125I]iodomelatonin ([125I]Mel) as radioligand at 25 degrees C. The specific binding of [125I]Mel was seen to be saturable, reversible, specific and of high affinity. In all the tissues assayed, the power of the ligands to inhibit [125I]Mel binding decreased in the following order: melatonin>>4-P-PDOT>luzindole> or =N-acetylserotonin, which points to the presence of Mel1-like receptors. The inhibition curves of 4-P-PDOT suggested the presence of two different binding sites in the brain areas, but only one type of site of low affinity in the neural retina. No daily variations in [125I]Mel binding capacity (Bmax) or affinity (Kd) were detected in the brain areas, while a clear rhythm in Kd melatonin receptor affinity and Bmax binding capacity was observed in the retina. Kd and Bmax retinal rhythms were out of phase with the lowest Kd and the highest Bmax occurring at scotophase. This result suggests that retinal melatonin is a paracrine factor able to control receptor desensitization during photophase when ocular melatonin is higher in this species.


Subject(s)
Bass/physiology , Brain/metabolism , Circadian Rhythm/physiology , Melatonin/analogs & derivatives , Receptors, Melatonin/metabolism , Retina/metabolism , Animals , Binding, Competitive , Iodine Radioisotopes , Kinetics , Melatonin/metabolism , Melatonin/pharmacology , Radioligand Assay
15.
Allergy ; 56(10): 1003-7, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11576082

ABSTRACT

BACKGROUND: Previous studies have shown elevated serum levels of the cytokines IL-4 and sCD23 in atopic patients and parasitic disease. Gastroallergic anisakiasis is an acute parasitic disease, accompanied by IgE-mediated clinical symptoms and an important increase of specific and total IgE. METHODS: Sixteen patients with acute urticaria/angioedema due to parasitism by Anisakis simplex after intake of raw or undercooked fish were selected, and serum samples were taken in the emergency room within 24 h (day 0; n=16), after 1 month (n=16), and after 6 months (n=10). Serum samples were studied for specific IgE against A. simplex, total IgE, sCD23, and IL-4. RESULTS: Mean values for sCD23 did not change in the observation period. Only 4/16 serum samples showed measurable IL-4 levels. Specific IgE and total IgE levels were found to be elevated after 1 month; after 6 months, they fell to nearly basal values. There was a positive correlation between sCD23 and specific IgE at day 0 and follow-up (r=0.55-0.69, P<0.026); a positive correlation between sCD23 and total IgE (r=0.54-0.62, P<0.056). Basal sCD23 could moderately predict the percentual increment of total IgE in the first month (r=0.56, P<0.038). CONCLUSION: Thus, it seems that interindividual variability of sCD23 is an important factor, with higher values predisposing to more production of unrelated IgE, independently of the parasite's action.


Subject(s)
Anisakiasis/immunology , Hypersensitivity, Immediate/immunology , Immunoglobulin E/biosynthesis , Receptors, IgE/blood , Animals , Anisakis/immunology , Antibodies, Helminth/biosynthesis , Antibodies, Helminth/blood , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunoglobulin E/blood , Interleukin-4/blood , Male , Middle Aged
16.
Physiol Behav ; 72(5): 629-34, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11336993

ABSTRACT

Feeding regulation by monoamines, neuropeptides and certain hormones has been studied in fish, but a possible role of melatonin is unknown. The purpose of the present study was to investigate the effects of melatonin on food intake in goldfish. Fishes were housed in 12L:12D and injected with different doses of either melatonin or 2-iodomelatonin. Two routes of administration, intracerebroventricular and intraperitoneal injections, and two times of the daily photocycle, midday and midnight, were tested. Food intake was measured at 2, 5 and 8 h postinjection. Melatonin and its analog, 2-iodomelatonin intracerebroventricularly injected had no effect on food intake at any time. However, intraperitoneal injections of both indoleamines significantly reduced food intake at different postinjection times. The inhibitory effect of melatonin was blocked by intraperitoneal administration of its antagonist, luzindole. These results demonstrate the in vivo efficiency of luzindole as melatonin antagonist, and thus provide a useful experimental tool to investigate melatonin functions. In conclusion, both melatonin and its agonist 2-iodomelatonin administered peripherally, inhibit food intake in goldfish, and this inhibitory effect appears to be mediated via luzindole-sensitive melatonin receptors. Our results strongly suggest that melatonin is involved in the peripheral satiety mechanisms in goldfish.


Subject(s)
Antioxidants/pharmacology , Eating/drug effects , Goldfish/physiology , Melatonin/pharmacology , Animals , Antioxidants/administration & dosage , Depression, Chemical , Injections, Intraperitoneal , Injections, Intraventricular , Melatonin/administration & dosage , Melatonin/analogs & derivatives , Tryptamines/pharmacology
17.
Neurosci Lett ; 300(3): 129-32, 2001 Mar 16.
Article in English | MEDLINE | ID: mdl-11226628

ABSTRACT

Concentration of dopamine (DA) and its metabolite, 3,4-dihydroxyphenylacetic acid is quantified by high-pressure liquid chromatography with a coulometric detection system in the eye of Xenopus laevis through ontogeny and in adults at two times during photocycle (midday and midnight). Ocular dopaminergic activity remains low during pre- and prometamorphosis and significantly rises in postmetamorphic froglets. This increase is more pronounced at midnight than at midday. The dualism of DA content versus DA release in Xenopus ocular tissue is studied in an eyecup culture system. On a 24-h cycle of DA release from adult Xenopus eyecups the highest DA release by eyecups is produced during daytime, and significantly decreases in darkness. From these results it can be concluded that in spite of the early development of the retinal dopaminergic system in the ontogeny of Xenopus, the final maturation must occur during the metamorphic climax. Endogenous DA release is significantly inhibited by light offset, which explains the higher ocular DA content found at midnight as compared to midday in postmetamorphic froglets and adults.


Subject(s)
3,4-Dihydroxyphenylacetic Acid/metabolism , Dopamine/metabolism , Eye/metabolism , Metamorphosis, Biological/physiology , Periodicity , Photoperiod , Animals , Darkness , Eye/growth & development , Female , Larva/growth & development , Larva/metabolism , Male , Xenopus laevis/growth & development
19.
Rev Esp Anestesiol Reanim ; 47(6): 245-51, 2000.
Article in Spanish | MEDLINE | ID: mdl-10981440

ABSTRACT

OBJECTIVE: To describe and assess the clinical usefulness of a new posterior approach for sciatic nerve block to the gluteal zone. PATIENTS AND METHODS: This prospective descriptive study of 40 adults undergoing lower limb surgery measured the difficulty, efficacy and success of the described sciatic nerve block. TECHNIQUE: the patient was placed in Sim's position for a posterior approach. A line was then drawn from the upper part of the iliac spine to the sacral hiatus. From the midpoint of that line, a second line of equal length, perpendicular to the first and medial, was then drawn. The end of that line was the point of puncture. The needle was inserted perpendicular to all planes. Mepivacaine 1.5% (0.3 ml/kg) was injected. RESULTS: The sciatic nerve was located upon the first attempt in 90% of the patients within 21.86 +/- 12.62 s. The block failed in 2.5%. Time taken to establish the block was 19.17 +/- 9.62 m. One transitory, mild complication occurred. No vascular puncture occurred. CONCLUSIONS: We describe a new approach for sciatic nerve block using only two points of osseous reference identified by palpation. The level of efficacy and safety is high.


Subject(s)
Nerve Block/methods , Sciatic Nerve , Buttocks , Female , Humans , Male , Middle Aged , Prospective Studies
20.
Alergol. inmunol. clín. (Ed. impr.) ; 15(4): 230-236, ago. 2000.
Article in Es | IBECS | ID: ibc-3453

ABSTRACT

En España, hasta 1995 los casos de anisakiasis eran anecdóticos. Sin embargo, en 1995, los alergologos españoles, de la mano del grupo del Dr. Fernández de Corres, llegan al Anisakis simplex (AS) por casos de reacciones alérgicas tras consumo de pescado "presumiblemente" bien cocinado y con pruebas cutáneas e IgE específica a AS positivas. La base de la alergia al AS parecía estar en la termoestabilidad de antígenos del AS. Tras observar algunos casos de anafilaxia con parasitación por AS, se inició un estudio prospectivo en 1997 en el Hospital Universitario "La Paz" de Madrid. Se introdujeron pacientes que acudían a urgencias con síntomas alérgicos o gastrointestinales tras ingestión de productos de mar, aceptando pacientes que hubieran tomado el alimento hasta 48 horas antes. Si el cuadro digestivo persistía se realizaba endoscopia. En 18 meses se evaluaron 120 pacientes que consultaron por síntomas alérgicos y de los cuales en 96 se implicó verdaderamente al AS. En esos 18 meses, y sobre la base de los síntomas de alergia, se detectaron 24 pacientes a los que se extrajo uno o más parásitos de su estómago (más parásitos hallados en sólo 18 meses que desde 1991 en España). El boquerón en vinagre y en algunos casos la merluza fresca, presumiblemente bien cocinada, fueron la fuente de la mayoría de las parasitaciones. Los autores denominaron a esta entidad anisakiasis gastro-alérgica diferenciándola de la anisakiasis gástrica, dado que los síntomas de hipersensibilidad tras el contacto con el parásito eran más intensos y severos que los gástricos. Parecía que en su mayoría era el parásito vivo la fuente antigénica y más aún, que necesitaba fijarse a la submucosa para producir la reacción de hipersensibilidad. El paso siguiente en estos pacientes con anisakiasis gastro-alérgica fue la provocación con parásitos congelados no infectivos. Se confirmó su tolerancia en varios pacientes y a partir de entonces al resto se les permitió comer pescado congelado sin suceder ningún problema. En ese punto, la alergia a proteínas termoestables del AS parecía menos frecuente de lo presupuesto y se intuía que la repuesta IgE mediada en la mayoría de los pacientes sensibilizados correspondía a contactos (parasitaciones en forma luminal o asintomáticas) con el parásito vivo. El antecedente dietético, la clínica, la respuesta a los test cutáneos y la medición seriada de IgE específica a AS son importantes claves para el diagnóstico. Puede que existan casos de verdadera alergia a AS, pero en vistas de este estudio prospectivo deben ser infrecuentes (AU)


Subject(s)
Humans , Anisakiasis/immunology , Hypersensitivity, Immediate/immunology , Prospective Studies , Seafood/parasitology , Intestinal Diseases, Parasitic/complications , Immunoglobulin E/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...